The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 209-216, January 2010

Defect of regulatory T cells in patients with Omenn syndrome

  • Barbara Cassani, PhD

      Affiliations

    • Fondazione Humanitas per la Ricerca, Rozzano (MI), Italy
  • ,
  • Pietro Luigi Poliani, MD, PhD

      Affiliations

    • Department of Pathology, University of Brescia, Brescia, Italy
  • ,
  • Daniele Moratto, PhD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
  • ,
  • Cristina Sobacchi, PhD

      Affiliations

    • CNR-Istituto Tecnologie Biomediche, Segrate (MI), Italy
    • IRCCS Istituto Clinico Humanitas, Rozzano (MI), Italy
  • ,
  • Veronica Marrella, PhD

      Affiliations

    • CNR-Istituto Tecnologie Biomediche, Segrate (MI), Italy
    • IRCCS Istituto Clinico Humanitas, Rozzano (MI), Italy
  • ,
  • Laura Imperatori, PhD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
  • ,
  • Donatella Vairo, PhD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
  • ,
  • Alessandro Plebani, MD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
  • ,
  • Silvia Giliani, PhD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
  • ,
  • Paolo Vezzoni, MD

      Affiliations

    • CNR-Istituto Tecnologie Biomediche, Segrate (MI), Italy
    • IRCCS Istituto Clinico Humanitas, Rozzano (MI), Italy
  • ,
  • Fabio Facchetti, MD, PhD

      Affiliations

    • Department of Pathology, University of Brescia, Brescia, Italy
  • ,
  • Fulvio Porta, MD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
  • ,
  • Luigi D. Notarangelo, MD

      Affiliations

    • Division of Immunology, Children's Hospital, Boston, Mass
    • Manton Center for Orphan Disease Research, Children's Hospital, Boston, Mass
  • ,
  • Anna Villa, MD

      Affiliations

    • CNR-Istituto Tecnologie Biomediche, Segrate (MI), Italy
    • San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy
    • These authors share senior authorship of this work.
    • Corresponding Author InformationReprint requests: Anna Villa MD, ITB-CNR, via F.lli Cervi 90, Segrate, Milan, Italy.
  • ,
  • Raffaele Badolato, MD, PhD

      Affiliations

    • Istituto di Medicina Molecolare “Angelo Nocivelli,” Department of Pediatrics, University of Brescia, Brescia, Italy
    • These authors share senior authorship of this work.

Received 4 May 2009; received in revised form 22 September 2009; accepted 16 October 2009.

Background

Omenn syndrome (OS) is an autosomal-recessive disorder characterized by severe immunodeficiency and T-cell–mediated autoimmunity. The disease is caused by hypomorphic mutations in recombination-activating genes that hamper the process of Variable (V) Diversity (D) Joining (J) recombination, leading to the generation of autoreactive T cells. We have previously shown that in OS the expression of autoimmune regulator, a key factor governing central tolerance, is markedly reduced.

Objective

Here, we have addressed the role of peripheral tolerance in the disease pathogenesis.

Methods

We have analyzed forkhead box protein P3 (FOXP3) expression in peripheral blood T cells of 4 patients with OS and in lymphoid organs of 8 patients with OS and have tested the suppressive activity of sorted CD4+ CD25high peripheral blood T cells in 2 of these patients.

Results

We have observed that CD4+CD25highT cells isolated ex vivo from patients with OS failed to suppress proliferation of autologous or allogenic CD4+ responder T cells. Moreover, despite individual variability in the fraction of circulating FOXP3+ CD4 cells in patients with OS, the immunohistochemical analysis of FOXP3 expression in lymph nodes and thymus of patients with OS demonstrated a severe reduction of this cell subset compared with control tissues.

Conclusion

Overall, these results suggest a defect of regulatory T cells in OS leading to a breakdown of peripheral tolerance, which may actively concur to the development of autoimmune manifestations in the disease.

Key words: Immunodeficiency, V(D)J recombination, Omenn syndrome, regulatory T cells, FOXP3, anergy and tolerance, thymus and the development of T lymphocytes

Abbreviations used: AIRE, Autoimmune regulator, FOXP3, Forkhead box protein P3, HD, Healthy donor, OS, Omenn syndrome, RAG, Recombination-activating gene, Treg, Regulatory T

 

 This work was supported by grants from the Italian Telethon Foundation to A.V., from Fondazione Cariplo (Nobel project to A.V., and L.D.N./R.B.), Fondazione Cariplo to A.V. and P.L.P., EU grant FP7 HLH-cure (project n. 201461), PRIN 2007 n. 2007ACZMMZ_005, Telethon GGP07241 to R.B., grant FIRB/MIUR (n. RBIN04CHXT) to P.V., Ministero della Salute RF2007 Giovani Ricercatori Grant to C.S., and the Manton Foundation to L.D.N.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01551-6

doi:10.1016/j.jaci.2009.10.023

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 209-216, January 2010